Overview

Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers

Status:
Completed

Trial end date:
2004-11-01

Target enrollment:

Participant gender:

Summary

This study will look at differences in bioanalytical measures among different groups of MS patients and Healthy Volunteers, when administered interferon beta-1a.

Phase:

Phase 4

Details

Lead Sponsor:

Biogen

Treatments:

Interferon beta-1a
Interferon-beta
Interferons